MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, AURA had -$59,800K decrease in cash & cash equivalents over the period. -$20,189K in free cash flow.

Cash Flow Overview

Change in Cash
-$59,800K
Free Cash flow
-$20,189K

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Cash Flow
2025-09-30
2025-06-30
Net loss
-26,130 -54,502
Depreciation expense
280 577
Accretion income on marketable securities
337 785
Stock-based compensation expense
3,688 7,347
Other non-cash items
0 27
Non-cash lease expense
392 757
Prepaid expenses and other assets
1,534 -2,882
Other long-term assets
92 -333
Accounts payable
602 -1,018
Accrued expenses and other liabilities
3,345 910
Operating lease liabilities
-358 -657
Net cash used in operating activities
-20,144 -44,129
Purchases of property and equipment
45 226
Purchases of marketable securities
73,974 9,984
Proceeds from sale of marketable securities
-0
Maturities of marketable securities
30,000 60,000
Net cash provided by investing activities
-44,019 49,790
Proceeds from exercise of stock options
1,008 2
Proceeds from issuance of common stock from follow-on offering, net of issuance costs
0 46,517
Proceeds from issuance of pre-funded warrants from follow-on offering, net of issuance costs
0 14,156
Proceeds from issuance of common stock warrants from follow-on offering, net of issuance costs
0 9,254
Proceeds from issuance of common stock under atm facility, net of issuance costs
3,287 -
Proceeds from espp purchases
68 96
Net cash provided by financing activities
4,363 70,025
Net increase (decrease) in cash, cash equivalents and restricted cash
-59,800 75,686
Effect of exchange rate changes on cash
-26 -
Cash and cash equivalents at beginning of period
32,461 -
Cash and cash equivalents at end of period
48,321 -
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Aura Biosciences, Inc. (AURA)

Aura Biosciences, Inc. (AURA)